***Meeting program subject to change.
Available Formats: = In Person
= On Demand
Welcome and Keynote Address
8:00–9:00 AM
Douglas A. Melton †, Vertex Pharmaceuticals
Treating T1D with PSC-Derived Islet Cells
Bringing the Future Forward: Cell Therapies Proving Potential in Trials
9:00–11:15 AM
Agnete Kirkeby, University of Copenhagen
Comprehensive Overview of the field of Cell Therapies
Jennifer Bahr-Davidson †, Lineage Cell Therapeutics
CMC Considerations for Late-Stage Clinical Development of OpRegen for dry AMD
Catherine Priest †, Neurona Therapeutics
NRTX-1001 Interneurons for Epilepsy
Short Talk(s) Chosen from Abstracts
Panel Discussion 1: Funding Cell Therapies
11:15–12:15 PM
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Scanning the Horizon: The Next Generation of Cell Therapies Under Development
5:00–7:00 PM
Ludovic Vallier †, Berlin Institute of Health at Charité
Therapy for Liver Disease
Stefan Irion, BlueRock Therapeutics
Cell Therapies for CNS Disease
Rob Coppes †, University Medical Center Groningen
Stem Cell Therapy for Radiation-Induced Hyposalivation
Short Talk(s) Chosen from Abstracts
Beyond the Cell: Building Multicellular Systems
8:00–11:00 AM
Christopher S. Chen, Boston University
Vascularization of Multicellular Implants
Krishanu Saha †, University of Wisconsin-Madison
Engineering the Next Generation of Cell Therapies
Kelly R. Stevens †, University of Washington
Synthetic Human Tissues from Stem Cells
Holger Andreas Russ †, University of Florida and Tolerance Bio
Restoring Thymic Function to Induce Tolerance
Short Talk Chosen fro Abstracts
Panel Discussion 2: The Second Valley of Death: How Cell Therapies can Survive in the Market Place
11:00–12:00 PM
Beyond the Tissue: The Realm of Whole Organ Transplantation
5:00–7:00 PM
Adam W. Feinberg †, Carnegie Mellon University
Bioprinting the Human Heart
Jennifer A. Lewis †, Harvard University, SEAS
Engineering the Kidney
Wenning Qin †, eGenesis
Safe and Effective HuCo Organs for Xenotransplantation
Short Talk(s) Chosen from Abstracts
Engineering Tolerance: Designing for Immune Acceptance
8:00–11:00 AM
Tobias Deuse †, University of California, San Francisco
Synthetic Immune Checkpoint Engagers to protect Allo-Grafts
Megan K. Levings †, University of British Columbia
Tregulatory Cells for Organ Transplantation
Vaneet Sandhu †, Fate Therapeutics
Clinical Trials for Autoimmune Disease
Short Talk(s) Chosen from Abstracts
Panel Discussion 3: Preclinical Models: Human Cells in a Murine World: The Challenges of Testing Human Cells in Rodents
11:00–12:00 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Engineering the Future: Cell and Tissue Therapies of Tomorrow
5:00–6:45 PM
Patrick D. Hsu †, Arc Institute | University of California, Berkeley
Computational Mining to Identify Tools for Biological Programming
Charlotte Bunne †, École Polytechnique Fédérale de Lausanne
Large Language Models and the Virtual Cell to Advance Cellular Therapies
Katie Galloway †, Massachusetts Institute of Technology
Synthetic Biology Tools for Mammalian Cell Engineering
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
